Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

Delayed Quote. Delayed  - 08/29 09:38:07 pm
50.81 USD   +0.10%
08/24 IMPLANTS : Your common questions answered
08/24 VALEANT PHARMAC : Pharma shake-up falls flat for investors
08/23DJNew CFO Tops Off Shake-Up At Valeant -- WSJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ZOETIS INC
08/24 IMPLANTS : Your common questions answered
08/24 VALEANT PHARMACEUTICALS INTL : Pharma shake-up falls flat for investors
08/23DJNew CFO Tops Off Shake-Up At Valeant -- WSJ
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
08/22 VALEANT PHARMACEUTICALS INTL : Appoints Paul S. Herendeen As Executive Vice Pres..
08/22 VALEANT PHARMACEUTICALS INTL : Reportedly Appoints Zoetis` Executive Paul Herend..
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
08/22DJValeant Names Zoetis Executive as CFO
08/22DJValeant to Tap New CFO, As Shake-Up Continues -- WSJ
08/22 ZOETIS : Announces Appointment of Glenn David as Executive Vice President and Ch..
08/22DJValeant Hiring Paul Herendeen From Zoetis as New CFO, Sources Say -- Update
08/22 VALEANT EXPECTED TO ANNOUNCE HERENDE : Wsj
08/19 ZOETIS : Among Top Companies in Brazil
08/13 ZOETIS : Fluke control depends on timing, dose
More most relevant news
All news about ZOETIS INC
08/24 IMPLANTS : Your common questions answered
08/24 VALEANT PHARMACEUTICALS INTL : Pharma shake-up falls flat for investors
08/23DJNew CFO Tops Off Shake-Up At Valeant -- WSJ
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
08/22 VALEANT PHARMACEUTICALS INTL : Appoints Paul S. Herendeen As Executive Vice Pres..
08/22 VALEANT PHARMACEUTICALS INTL : Reportedly Appoints Zoetis` Executive Paul Herend..
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
08/22DJValeant Names Zoetis Executive as CFO
08/22 ZOETIS INC. : Change in Directors or Principal Officers (form 8-K)
More news
Sector news : Veterinary Drugs
01:56pDJMYLAN : Feeling Heat on EpiPen Price, Will Offer Cheaper Generic
11:29aDJROCHE : Receives US FDA Emergency Use Authorization for Zika Test -- Update
11:10aDJROCHE : Receives US FDA Emergency Use Authorization for Zika Test
09:29aDJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
More sector news : Veterinary Drugs
News from SeekingAlpha
08/22 WALL STREET BREAKFAST : Pfizer Closes In On $14B Takeover Of Medivation
08/22 Zoetis' CFO leaves company to join Valeant - DJ
08/18 Tracking George Soros's Portfolio - Q2 2016 Update
08/17 Tracking Bill Ackman's Pershing Square Portfolio - Q2 2016 Update
08/06 Pet Owners May Be Crazy About Their Pets, But Investors Should Avoid Overvalu..
08/04 Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q2 ..


Advertisement
Financials ($)
Sales 2016 4 879 M
EBIT 2016 1 540 M
Net income 2016 798 M
Debt 2016 3 541 M
Yield 2016 0,73%
P/E ratio 2016 31,58
P/E ratio 2017 24,32
EV / Sales 2016 5,88x
EV / Sales 2017 5,26x
Capitalization 25 128 M
More Financials
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Full-screen chart
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 54,5 $
Spread / Average Target 7,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC5.93%25 128
JINYU BIO-TECHNOLOGY C..49.34%2 567
SHANGHAI HILE BIO TECH..-91.12%1 919
VIRBAC-12.19%1 761
DECHRA PHARMACEUTICALS..22.14%1 627
PULIKE BIOLOGICAL ENGI..-16.87%1 143
More Results